✦ LIBER ✦

53 A phase I study of epidermal growth factor receptor (EGFR) antibody EMD 72000 in combination with paclitaxel (P) in patients (pts) with EGFR-positive advanced non-small cell lung cancer (NSCLC)

✍ Scribed by C. Bokemeyer; C. Kollmannsberger; M. Schittenhelm; F. Honecker; H.J. Ahrens; J. Tillner; L. Kanz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-245 Randomized phase II clinical trial

✍ Rosell, Rafael; Constenla, Manuel; Kolb, Rainer; Pfeiffer, Wolfang; O'Bryne, Ken 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

PD-151 Mutations in the epidermal growth

✍ Nederlof, P.; Boerrigter, L.; van 't Veer, L.; Baas, P.; van Zandwijk, N. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB

A phase II study of Erbitux (IMC-C225),

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

P-48 Phase I study of nedaplatin (N) in

✍ Nogami, Toshiji; Tamra, Kenji; Kurata, Takayasu; Uejima, Hisao; Nakagawa, Kazhik 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Pilot trial of ZD1839 (IressaTM), an ora

✍ Laurie, S.A; Miller, V.A; Johnson, D; Ng, K.K; Heelan, R.T; Pizzo, B.A; Perez, W 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

55 Randomized phase II clinical trial of

✍ R. Rosell; R. Ramlau; A. Szczesna; C. Daniel; M. Bertrand; R. Garcia-Arroyo; K. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB